Koutif Therapeutics, LLC — Form D/A
Koutif Therapeutics, LLC of CLEVELAND, OH, a company, filed a Form D amendment with the SEC on 2018-10-02. The offering totals $5.0M, of which $2.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-10-02
- Form: D/A
- Accession: 0001710166-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.6M
- Remaining: $2.4M
- Investors: 3
- Date of first sale: 2017-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-296006
Issuer
- Name: Koutif Therapeutics, LLC
- CIK: 0001710166
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 20600 CHAGRIN BOULEVARD, CLEVELAND, OH, 44122
- Phone: 216-455-3200
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Baiju R Shah | Director | Cleveland, OH |
| Baiju R Shah | Executive Officer | Cleveland, OH |
Other filings by this issuer (1)
More